CRP and cardiovascular disorder: As demonstrations of our approach, we developed sensors for two human biomarkers—monomeric C-reactive protein and interleukin-32γ protein—that have been previously used as serum-accessible proxies for cardiovascular disease, pro-inflammatory conditions, and pathogen infection.